Danish pharmaceutical company Novo Nordisk recently announced plans to spend approximately $1.2 billion to build a new production facility in Odense, Denmark.
As part of a comprehensive $1-billion multiphase expansion of Analog Devices’ semiconductor factory to enhance its manufacturing capabilities, this $115-million project adds 25,000 sq ft of clean room capacity, bringing the client’s total manufacturing space up to 118,000 sq ft.
This large and complex expansion of a biologic medicine manufacturing plant increased capacity 75% by adding three production bioreactors, each 15,400 liters, as well as associated seed reactors and expanded warehouse cold rooms, freezers and central utilities.
The team behind this 8,500-sq-m single-use, monoclonal antibody biotech production facility for animal medication needed to meet its schedule targets so the owner could meet the earliest possible product-to-market date.
Situated on 69 acres, this $61-million 917,374-sq-ft business park hosts four Class A buildings, with scope including full-site development of all utilities, gas, water and roads on three separate sites.
Spanning 138,000 sq ft, this state-of-the-art fluid milk facility is the first vertically integrated Class 1 and Class 2 dairy processing plant in the state of Idaho, meaning it has the capacity to process and package products in one location.
To strengthen the delivery logistics required to efficiently service 24 hospitals and 160 clinics across the Intermountain West, this $16-million expansion brings an additional 46,000 sq ft to this fulfillment center and pharmacy.
Constructed on an 80-acre greenfield site, this 365,000-sq-ft plant increases Hill’s pet food production capacity with custom process and quality systems that incorporate new methods for mixing powders and liquids and for handling meat.